Reshaping the HIV treatment and prevention landscape
Oncology strategy focused on the science
of the immune system and human genetics
gsk
Immuno-oncology and cell therapy
Blenrep
Science of the
immune system
Harness the power of the
immune system to target
cancer via next generation
checkpoint modulators and
cell and gene therapies
Jemperli*
Human
genetics
Develop therapeutic agents
based on biology, validated
through genetics
LAG-3*
TIGIT
CD96
TIM-3*
Pre clinical
PVRIG
NY-ESO-1 TCR
NY-ESO-1/TGFbR2 TCR T
NY-ESO-1/CD8a TCRT
STING
ICOS agonist
TGF beta trap / anti-PDL1
Synthetic lethality
Zejula
PRMT-5
Type 1 PRMT
MAT2A
Pre clinical
Pol Theta
Werner Helicase
*Tesaro asset
SURFACE
ONCOLOGY.
Merck
iTeos
Therapeutics
AnaptysBio
IDEAVA
BIOSCIENCES
immatics
Lyell
X
23andMe
»Adaptimmune
TRANSFORMING T CELL THERAPY
89View entire presentation